In particular, p-tau217 has garnered special attention due to its superior performance compared to other p-tau species in distinguishing patients at different stages of AD, from preclinical to dementia, and differentiating AD from other neurodegenerative disorders [15,19,20,21]. Here, MAPT is linked to Alzheimer disease.